Friday, July 10, 2026

Drug profile · INN

tramadol hydrochloride

tramadol hydrochloride (TRAMADOL HYDROCHLORIDE) is a mu opioid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — tramadol hydrochloride
US status
approved
Class
Route
ORAL
Patents
0
Programs
1
Data quality
0.89

Quick answer

tramadol hydrochloride (TRAMADOL HYDROCHLORIDE) is a mu opioid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN tramadol hydrochloride
Brand TRAMADOL HYDROCHLORIDE
Mechanism Mu opioid receptor agonist
Target Mu-type opioid receptor
Route ORAL
Formulation TABLET, ORALLY DISINTEGRATING

Mechanism of action

Mu opioid receptor agonist

Primary target: Mu-type opioid receptor

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. AMY106EU Phase 2 · Anaxis Pharma · Endometriosis

Related & competitor drugs

  1. alvimopan Mu opioid receptor antagonist
  2. loperamide hydrochloride Mu opioid receptor agonist
  3. methadone hydrochloride Mu opioid receptor agonist
  4. morphine sulfate Mu opioid receptor agonist
  5. oxycodone Mu opioid receptor agonist
  6. oxycodone hydrochloride Mu opioid receptor agonist

Frequently asked questions

What is tramadol hydrochloride?

tramadol hydrochloride (TRAMADOL HYDROCHLORIDE) is a mu opioid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for tramadol hydrochloride?

TRAMADOL HYDROCHLORIDE is a marketed brand name for tramadol hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of tramadol hydrochloride?

tramadol hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.